Q4129277 (Q4129277): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Changed label, description and/or aliases in es, and other parts: Adding Spanish translations) |
||||||||||||||
| label / es | label / es | ||||||||||||||
(0350000132) HIDROXITIROSOL Y COVID-19 | |||||||||||||||
| Property / summary | |||||||||||||||
(0350000132) HIDROXITIROSOL Y COVID-19 (Spanish) | |||||||||||||||
| Property / summary: (0350000132) HIDROXITIROSOL Y COVID-19 (Spanish) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: (0350000132) HIDROXITIROSOL Y COVID-19 (Spanish) / qualifier | |||||||||||||||
point in time: 30 January 2022
| |||||||||||||||
Revision as of 11:13, 30 January 2022
Project Q4129277 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q4129277 in Italy |
Statements
10,500.0 Euro
0 references
21,000.0 Euro
0 references
50.0 percent
0 references
P&P FARMA SRL
0 references
(0350000132) IDROSSITIROSOLO E COVID-19 (Italian)
0 references
TORINO
0 references